Cargando…

481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome

OBJECTIVES/GOALS: Buprenorphine (BUP) is used for opioid use disorder during pregnancy but causes neonatal opioid withdrawal syndrome (NOWS). The goal of this study was to determine the contribution of the active metabolite, norbuprenorphine (NorBUP), to the development of NOWS when the parent drug,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tobacyk, Julia, Parks, Brian J., Coward, Lori, Berquist, Michael D., Gorman, Gregory S., Brents, Lisa K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129499/ http://dx.doi.org/10.1017/cts.2023.494

Ejemplares similares

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
por: Janganati, Venumadhav, et al.
Publicado: (2023)

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals
por: Webster, Lynn R, et al.
Publicado: (2016)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021)

384 Motives for kratom self-medication: contents of public comments solicited by the FDA
por: Tobacyk, Julia, et al.
Publicado: (2022)

Association Between Buprenorphine Dose and the Urine “Norbuprenorphine” to “Creatinine” Ratio: Revised
por: Furo, Hiroko, et al.
Publicado: (2023)

Buprenorphine and Norbuprenorphine Determination in Mice Plasma and Brain by Gas Chromatography–Mass Spectrometry
por: Chiadmi, Fouad, et al.
Publicado: (2014)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
por: Eudy‐Byrne, Rena, et al.
Publicado: (2021)

Corrigendum to: Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
Publicado: (2022)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
por: Chavan, Niraj R., et al.
Publicado: (2017)

Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop
por: Simon, Alan E., et al.
Publicado: (2021)

Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants
por: Devlin, Lori A., et al.
Publicado: (2021)

Single high-dose buprenorphine for opioid craving during withdrawal
por: Ahmadi, Jamshid, et al.
Publicado: (2018)

Opioid Withdrawal Presenting as Delirium and Role of Buprenorphine: A Case Series
por: Das, Sourav, et al.
Publicado: (2017)

BUPRENORPHINE WITHDRAWAL SYNDROME
por: Tripathi, B.M., et al.
Publicado: (1995)

Efficient Synthesis of Norbuprenorphines Coupled with Enkephalins and Investigation of Their Permeability
por: Balalaie, Saeed, et al.
Publicado: (2019)

Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
por: Lund, Ingunn O, et al.
Publicado: (2012)

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
por: K. K., Adams, et al.
Publicado: (2022)

A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal
por: Chisamore, Brian, et al.
Publicado: (2016)

Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
por: Szczesniak, Laura M., et al.
Publicado: (2020)

Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
por: Adams, K. K., et al.
Publicado: (2021)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series
por: Spadaro, Anthony, et al.
Publicado: (2023)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome
por: Baldo, Brian A.
Publicado: (2022)

Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns
por: Esposito, Daina B., et al.
Publicado: (2022)

Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS)
por: Stevens, Sarah, et al.
Publicado: (2021)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

A Novel Strategy for Attenuating Opioid Withdrawal in Neonates
por: Santoro, Giovanni C, et al.
Publicado: (2016)

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
por: Hassan, Rahimah, et al.
Publicado: (2021)

Addressing drivers of healthcare utilization for neonatal opioid withdrawal syndrome
por: Glait, Megan, et al.
Publicado: (2022)

Molecular and long-term behavioral consequences of neonatal opioid exposure and withdrawal in mice
por: Dunn, Amelia D., et al.
Publicado: (2023)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Norbuprenorphine Interferences in Urine Drug Testing LC–MS-MS Confirmation Methods from Quetiapine Metabolites
por: Muñoz-Muñoz, Ana Celia, et al.
Publicado: (2021)

Correction to Lancet Oncol 2013; 14: 481
Publicado: (2013)

SAT-481 TSH Adenoma: An Elusive Diagnosis
por: Chaudhary, Hira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t0be0p7i2acura02f41se8ctsp